Karachi: Otsuka Pakistan Ltd. has announced that its Board of Directors will convene on Wednesday, September 2, 2026, at 11:30 a.m. at the company's registered office in Karachi. The meeting will focus on the review and approval of the annual accounts for the fiscal year ending June 30, 2026. The agenda also includes other routine matters pertinent to the company's operations.

The company has declared a "Closed Period" starting from August 27, 2026, extending through the day of the meeting on September 2, 2026. During this time, directors, executives, and designated employees are prohibited from dealing in the company's shares.

According to information available from the Pakistan Stock Exchange (PSX), the designation of a closed period is a standard practice designed to prevent insider trading and maintain market integrity ahead of significant financial disclosures.

Otsuka Pakistan Ltd., a notable entity in the pharmaceutical sector, continues to adhere to regulatory requirements, underscoring its commitment to transparency and governance. The outcome of the board meeting and the approved annual accounts will be closely monitored by investors and stakeholders within the market.